Beyond IL-16, CD163—a macrophage-specific hemoglobin scavenger receptor upregulated during inflammation—has been consistently identified as a urinary biomarker through ELISA and single-cell transcriptomics techniques in patients with LN [51,52,53]. Here, IL16 is linked to lobular neoplasia.